chief compliance officer round table2 jill fallows-macaluso, bsn, jd vice president and chief...
TRANSCRIPT
![Page 1: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/1.jpg)
1
Chief Compliance Officer Round Table
November 7, 2018, 3:45 p.m.
![Page 2: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/2.jpg)
22
Jill Fallows-Macaluso, BSN, JDVice President and Chief Compliance Officer Novo Nordisk Inc.Plainsboro, NJ
Robert A. Ladd, JDVice President, Global Head Integrity & Compliance, Oncology Novartis East Hanover, NJ
Panel Introductions
Moderator: Paul SilverPrincipal, Regulatory & Compliance Life Sciences Leader, Deloitte & Touche LLPAtlanta, Georgia
Jonathon L. KellermanExecutive Vice President and Global Chief Compliance Officer Allergan PLCNew York, NY
Puja Leekha, JDVice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance Lundbeck Pharmaceuticals LLC Deerfield, IL
Lori QueisserVice President, Chief Senior Vice President and Global Chief Compliance OfficerTeva Horsham, PA
Eric Siegel, Esq.Chief Compliance OfficerJazz Pharmaceuticals, Inc.Philadelphia, PA
![Page 3: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/3.jpg)
3
Today’s Topics
Compliance PhilosophyCompliance Philosophy
Culture of Ethics and ComplianceCulture of Ethics and Compliance
Measuring Compliance EffectivenessMeasuring Compliance Effectiveness
![Page 4: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/4.jpg)
44
• Type of Company - pharma, med device, biotech…
• Size of Company – Small, Medium, or Large
• How many people are in your Compliance Department
Getting to Know You
![Page 5: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/5.jpg)
55
Instructions for Accessing the Live Polling
In the Conference App, swipe to the Ask a Question button. Enter the code: Pharma2018. At the top of the screen
choose Polls.
Or open your Browser and go to Sli.doEnter the code: Pharma2018
Tap Polls at the top of the screen. The poll will be on the screen.
![Page 6: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/6.jpg)
66
Audience Polling #1
Your company is…A. Pharmaceutical
B. Medical Device
C. Biotech
D.A & B
E. A&C
F. B&C
G.A, B, and C
H.None of the above
![Page 7: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/7.jpg)
77
Audience Polling #2
Your company’s revenue is…
A. Less than $1B
B. $1B to $5B
C. $6B to $10B
D.$11B to $20B
E. More than $20B
![Page 8: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/8.jpg)
88
Audience Polling #3
How many people are in your Compliance Department?
A. 1 to 5
B. 6 to 10
C. 11 to 15
D.16 to 25
E. 26 to 35
F. 36 to 50
G.Over 50
![Page 9: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/9.jpg)
99
Audience Polling #4
Where does your company’s Compliance Department reside?
A. Stand alone department
B. Legal
C. Finance
D.Other
E. None of the above
![Page 10: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/10.jpg)
1010
Audience Polling #5 Is your company currently operating under
a CIA, DPA, or other court-ordered decree?A. Yes
B. No
If yes, has it changed where your department resides?
A. Yes
B. No
![Page 11: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/11.jpg)
1111
Topic 1: What is your Compliance Philosophy?
• Principles-based vs. Rules-based Compliance
‒ What does this mean to you?
‒ What does this mean to your department?
‒ What does this mean to your company?
![Page 12: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/12.jpg)
1212
Audience Polling #6Where is your company’s compliance
mindset and approach on the spectrum of reactive to proactive?
Purely Reactive
Proactive
1 2 3 4 5
![Page 13: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/13.jpg)
13
How does the legislative landscape impact your Compliance landscape?
![Page 14: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/14.jpg)
14
How does Compliance in the digital age create unique challenges and opportunities for your department and the broader enterprise?
![Page 15: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/15.jpg)
1515
Audience Polling #7
Is your compliance department more tactical or strategic?
A. Tactical
B. Strategic
C. Both
![Page 16: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/16.jpg)
1616
Topic 2: Measuring Compliance Effectiveness
• How does your company measure compliance effectiveness?
![Page 17: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/17.jpg)
17
What does success in compliance “look” like? What does it mean to you?Are you measured on it and, if so, how?
![Page 18: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/18.jpg)
18
What have been/are the keys to your program success?
![Page 19: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/19.jpg)
1919
Topic 3: Culture of Ethics and Compliance
• Companies based on ethics and trust are more successful.
![Page 20: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/20.jpg)
20
How can the Compliance Department help support the needs of patients?
![Page 21: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/21.jpg)
21
Are Compliance and Ethics part ofyour team’s performance evaluation?
How do you create opportunities for the growth of your team?
What career growth do you see forpeople in compliance?
Your Team
![Page 22: Chief Compliance Officer Round Table2 Jill Fallows-Macaluso, BSN, JD Vice President and Chief Compliance Officer Novo Nordisk Inc. Plainsboro, NJ Robert A. Ladd, JD Vice President,](https://reader033.vdocuments.us/reader033/viewer/2022052017/60302ef6a5540f4e7a38d8ee/html5/thumbnails/22.jpg)
22Thank you!
Questions?